Company intelligence / Profile preview

River Corporate Advisors

New York, New York, United Statesrivercorpadvisors.com ↗

Ownership: Private
Development stage: Phase 2

Overview

River Corporate Advisors provides investment banking and strategic advisory services to healthcare service and information technology companies. It does not develop drugs or medical products.

Industry: Consulting

Drug pipeline

2 assets

PHP-303

Phase 2

Indications: Alpha-1 antitrypsin deficiency, Acute respiratory distress syndrome

1 more asset in the full pipeline.

Request access →

Partnerships

Works with management teams, boards, and shareholders of healthcare service and IT companies as clients/advisory relationships—not pharma partnerships in the traditional sense.

Beyond the preview

Go deeper on River Corporate Advisors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on River Corporate Advisors.

Explore the full profile